Fact Sheet: SAMHSA 42 CFR Part 2 Revised Rule

14. July 2020 EHR, EMR, Health, HIPAA 0
The 42 CFR Part 2 regulations (Part 2) serve to protect patient records created by federally assisted programs for the treatment of substance use disorders (SUD). Part 2 has been revised to further facilitate better coordination of care in response to the opioid epidemic while maintaining its confidentiality protections against unauthorized disclosure and use. What ...

Health Privacy Rule 42 CFR Part 2 Is Revised, Modernizing Care Coordination for Americans Seeking Treatment for Substance Use Disorders

14. July 2020 EHR, EMR, Health, HIPAA 0
The Substance Abuse and Mental Health Services Administration (SAMHSA), part of the U.S. Department of Health and Human Services (HHS or Department), announces the adoption of the revised Confidentiality of Substance Use Disorder Patient Records regulation, 42 CFR Part 2. The adoption of this revised rule represents a historic step in expanding care coordination and ...

HHS Announces Over $4 Billion in Additional Relief Payments to Healthcare Providers Impacted by the Coronavirus Pandemic

11. July 2020 EHR, EMR, Health, HIPAA 0
Today, the U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), is announcing approximately $3 billion in funding to hospitals serving a large percentage of vulnerable populations on thin margins and approximately $1 billion to specialty rural hospitals, urban hospitals with certain rural Medicare designations, and hospitals in ...

HHS Releases May and June COVID-19 State Testing Plans

11. July 2020 EHR, EMR, Health, HIPAA 0
Today, the U.S. Department of Health and Human Services (HHS) made May and June COVID-19 Testing Plans from all states, territories, and localities publicly available on HHS.gov. The State Testing Plans serve as a roadmap for each state’s 2019 testing strategy for SARS-CoV-2, the virus that causes COVID-19. The plans include details on response to ...

HHS Awards More Than $21 Million to Support Health Centers’ COVID-19 Response

10. July 2020 EHR, EMR, Health, HIPAA 0
Today, the U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), awarded more than $21 million to support health centers’ COVID-19 response efforts. The majority of this investment—$17 million—supports 78 Health Center Program look-alikes (LALs) with funding to expand capacity for COVID-19 testing. Due to the urgent need ...

HHS, DOD Collaborate with Novavax to Produce Millions of COVID-19 Investigational Vaccine Doses in Commercial-Scale Manufacturing Demonstration Projects

08. July 2020 EHR, EMR, Health, HIPAA 0
The U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) today jointly announced a $1.6 billion agreement with Novavax, Inc. of Gaithersburg, Maryland, to demonstrate commercial-scale manufacturing of the company’s COVID-19 investigational vaccine. By funding this manufacturing effort, the federal government will own the 100 million doses of investigational vaccine expected ...

HHS Launches ‘Surge’ COVID-19 Testing in Hotspot Jurisdictions in Florida, Louisiana and Texas

08. July 2020 EHR, EMR, Health, HIPAA 0
Today, the U.S. Department of Health and Human Services (HHS) is announcing free COVID-19 testing in Jacksonville, Florida; Baton Rouge, Louisiana; and Edinburg, Texas. Surge testing efforts will temporarily increase federal support to communities where there has been a recent and intense level of new cases and hospitalizations related to the ongoing outbreak. The three ...

HHS, DOD Collaborate with Regeneron on Large-Scale Manufacturing Demonstration Project of COVID-19 Investigational Therapeutic Treatment

08. July 2020 EHR, EMR, Health, HIPAA 0
The U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) today announced an agreement with Regeneron, Inc. of Tarrytown, New York, to demonstrate commercial-scale manufacturing of the company’s COVID-19 investigational anti-viral antibody treatment, REGN-COV2. By funding this manufacturing effort, the federal government will own the doses expected to result from the ...